基于受控词表的不良反应信号词典用于多中心电子病历药物警戒
研究开发了基于受控词表的不良反应信号词典CVAD,将ICD、LOINC、ICNP等编码映射至MedDRA和WHO-ART术语。在SIDER 4.1的4514个MedDRA PT中,分别有1130、942和83个术语映射至临床叙述、实验室结果和疾病分类。CVAD覆盖率高,支持基于电子病历的多中心药物警戒信号检测。
要点
- CVAD整合标准受控词表,覆盖SIDER中25.03%的MedDRA PT。
- 词典映射临床叙述、实验室结果和疾病分类至ADR术语。
- 专家评审和三种药物ADR案例分析支持CVAD临床相关性。
核心结论
- CVAD对ADR覆盖率高,整合标准受控词表与EHR数据源,可用于大规模药物警戒研究。
研究设计与样本
- 开发并评估基于受控词表的ADR信号词典CVAD,映射ICD、LOINC、ICNP至MedDRA和WHO-ART。
主要发现
- SIDER 4.1的4514个MedDRA PT中,1130个(25.03%)映射至临床叙述,942个(20.86%)映射至实验室结果,83个(1.83%)映射至疾病分类。
- 临床专家评审了CVAD的临床相关性,并进行了三种药物ADR案例分析。
临床怎么用
- 研究者可利用CVAD进行基于EHR观察数据的广泛药物警戒研究,以提高灵敏度和特异度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Integration of controlled vocabulary-based electronic health record (EHR) observational data is essential for real-time large-scale pharmacovigilance studies. OBJECTIVE: To provide a semantically enriched adverse drug reaction (ADR) dictionary for post-market drug safety research and enable multicenter EHR-based extensive ADR signal detection and evaluation, we developed a comprehensive controlled vocabulary-based ADR signal dictionary (CVAD) for pharmacovigilance. METHODS: A CVAD consists of (1) administrative disease classifications of the International Classification of Diseases (ICD) codes mapped to the Medical Dictionary for Regulatory Activities Preferred Terms (MedDRA® PTs); (2) two teaching hospitals' codes for laboratory test results mapped to the Logical Observation Identifiers Names and Codes (LOINC) terms and MedDRA® PTs; and (3) clinical narratives and ADRs encoded by standard nursing statements (encoded by the International Classification for Nursing Practice [ICNP]) mapped to the World Health Organization-Adverse Reaction Terminology (WHO-ART) terms and MedDRA® PTs. RESULTS: Of the standard 4514 MedDRA® PTs from Side Effect Resources (SIDER) 4.1, 1130 (25.03%), 942 (20.86%), and 83 (1.83%) terms were systematically mapped to clinical narratives, laboratory test results, and disease classifications, respectively. For the evaluation, we loaded multi-source EHR data. We first performed a clinical expert review of the CVAD clinical relevance and a three-drug ADR case analyses consisting of linezolid-induced thrombocytopenia, warfarin-induced bleeding tendency, and vancomycin-induced acute kidney injury. CONCLUSION: CVAD had a high coverage of ADRs and integrated standard controlled vocabularies to the EHR data sources, and researchers can take advantage of these features for EHR observational data-based extensive pharmacovigilance studies to improve sensitivity and specificity.
引用
- Lee S, Han J, Park RW, et al. Development of a Controlled Vocabulary-Based Adverse Drug Reaction Signal Dictionary for Multicenter Electronic Health Record-Based Pharmacovigilance. Drug Saf. 2019. PMID: 30649749. doi:10.1007/s40264-018-0767-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。